Validation of the LENT score in Japanese sample: The impact of EGFR-TKI

Tamaki Takahashi (Kyoto, Japan), Tamaki Takahashi, Daisuke Naito, Yusuke Wakatsuki, Yuko Yamamoto, Yoko Hamakawa, Kazuki Shima, Yuichi Chihara, Kenichi Takahashi, Hiromichi Katakura, Naoki Sakai

Source: International Congress 2015 – Mediastinal tumors, malignant pleural mesothelioma and other rare tumors
Session: Mediastinal tumors, malignant pleural mesothelioma and other rare tumors
Session type: Thematic Poster Session
Number: 4328
Disease area: Thoracic oncology

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Tamaki Takahashi (Kyoto, Japan), Tamaki Takahashi, Daisuke Naito, Yusuke Wakatsuki, Yuko Yamamoto, Yoko Hamakawa, Kazuki Shima, Yuichi Chihara, Kenichi Takahashi, Hiromichi Katakura, Naoki Sakai. Validation of the LENT score in Japanese sample: The impact of EGFR-TKI. Eur Respir J 2015; 46: Suppl. 59, 4328

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Lung cancer after lymphoma: Disease characteristics, detection methods and clinical outcome
Source: Annual Congress 2013 –Other thoracic tumours, particular circumstances and rare cases
Year: 2013

Development and validation of a prognostic index for survival in patients with non-small-cell lung cancer
Source: International Congress 2016 – Prognostic variables in lung cancer II
Year: 2016


Assessment of fatigue using the identity-consequence fatigue scale in patients with lung cancer
Source: International Congress 2016 – Surgical strategy for complex diseases
Year: 2016

Prognostic value of EGFR mutation in NSCLC in surgical stage
Source: International Congress 2014 – Biology and pathology of thoracic tumours
Year: 2014

Comorbitities, responses and survival in pts with NSCLC
Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours
Year: 2014

Anxiety and depression in lung cancer patients - are there any relations to clinico-pathological characteristics?
Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours
Year: 2014

Assessment of nutritional status in patients with primary lung cancer
Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series
Year: 2014


Improving NLST criteria for lung cancer screening
Source: International Congress 2014 – Improving diagnosis of thoracic tumours
Year: 2014


Updating the EORTC questionnaire for assessing quality of life in lung cancer patients (EORTC QLQ-LC13)
Source: International Congress 2016 – Quality management and quality of life in lung cancer
Year: 2016


The prognostic value of KRAS mutation according to the gene's
Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours
Year: 2014

Predictors of lung cancer patients delay time in Serbia - a cross-sectional study
Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours
Year: 2014


Methilation status in EBUS-NA samples of lung cancer
Source: International Congress 2014 – Improving diagnosis of thoracic tumours
Year: 2014

Integrative analysis of DNA copy number in metastatic NSCLC identifies drug sensitivity to Afatinib
Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours
Year: 2014

Gefitinib in front line treatment of patients with NSCLC in the Czech Republic: Analysis of 113 patients
Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series
Year: 2014


Prognostic value of preoperative C-reactive protein in resectable non-small cell lung cancer - 5-years prospective study
Source: International Congress 2014 – Diagnosis, imaging and surgery for thoracic tumours
Year: 2014

Chemotherapy beyond 3rd line in NSCLC – A retrospective analysis
Source: International Congress 2015 – Lung cancer therapy: clinical trials
Year: 2015

Second primary lung cancer in squamous NSCLC patients: The Nancy Biobank's database
Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours
Year: 2014

Prognostic systems in advanced non small cell lung cancer (NSCLC): A validation study by the European Lung Cancer Working Party (ELCWP)
Source: Annual Congress 2010 - Treatment of lung cancer
Year: 2010

Survival in lung cancer: Associated factors in Tunisian patients
Source: International Congress 2015 – Thoracic oncology around the world: rare cases and local features
Year: 2015


Depression and personality in lung cancer patients
Source: Annual Congress 2013 –The latest insights in respiratory muscles, neuromuscular disease and comorbidities
Year: 2013